LIXTE BIOTECHNOLOGY HLDGS IN's ticker is LIXT and the CUSIP is 539319202. A total of 13 filers reported holding LIXTE BIOTECHNOLOGY HLDGS IN in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $58,783 | +62.5% | 71,054 | 0.0% | 0.00% | – |
| Q4 2022 | $36,166 | -9.6% | 71,054 | 0.0% | 0.00% | – |
| Q3 2022 | $40,000 | -24.5% | 71,054 | 0.0% | 0.00% | – |
| Q2 2022 | $53,000 | -39.1% | 71,054 | 0.0% | 0.00% | – |
| Q1 2022 | $87,000 | +2.4% | 71,054 | 0.0% | 0.00% | – |
| Q4 2021 | $85,000 | -42.6% | 71,054 | 0.0% | 0.00% | – |
| Q3 2021 | $148,000 | -31.2% | 71,054 | 0.0% | 0.00% | – |
| Q2 2021 | $215,000 | +211.6% | 71,054 | +237.5% | 0.00% | – |
| Q1 2021 | $69,000 | – | 21,053 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ethos Financial Group, LLC | 248,084 | $205,240 | 0.07% |